Arrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering
💵 Arrowhead Pharmaceuticals pays $215M for PRV: The drugmaker tucked into an SEC filing that it will pay that amount — the highest price tag this year for a ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.





